Literature DB >> 10475719

Attenuation of some subjective effects of amphetamine following tyrosine depletion.

S F McTavish1, M H McPherson, T Sharp, P J Cowen.   

Abstract

Fifteen healthy volunteers received d-amphetamine (20 mg orally) 2 h after ingesting either a nutritionally balanced amino acid mixture or one lacking the catecholamine precursors, tyrosine and phenylalanine (TYR-free). Plasma tyrosine levels were significantly lowered in subjects who received the TYR-free mixture but mean plasma amphetamine levels were higher. Despite this, the TYR-free mixture appeared to decrease the subjective psychostimulant effects of amphetamine, as determined by visual analogue scales. In contrast, the TYR-free mixture failed to lower the subjective anorectic effect of amphetamine. These findings are consistent with animal experimental studies indicating that tyrosine depletion attenuates the release of dopamine produced by amphetamine but not the release of noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475719     DOI: 10.1177/026988119901300205

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  17 in total

1.  Dietary tyrosine/phenylalanine depletion effects on behavioral and brain signatures of human motivational processing.

Authors:  James M Bjork; Steven J Grant; Gang Chen; Daniel W Hommer
Journal:  Neuropsychopharmacology       Date:  2013-09-02       Impact factor: 7.853

Review 2.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

3.  Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study.

Authors:  N Coupland; L Zedkova; G Sanghera; M Leyton; J M Le Mellédo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

4.  The effects of acute tyrosine and phenylalanine depletion on spatial working memory and planning in healthy volunteers are predicted by changes in striatal dopamine levels.

Authors:  Mitul A Mehta; Deepa Gumaste; Andrew J Montgomery; Sarah F B McTavish; Paul M Grasby
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

5.  Dopamine precursor depletion improves punishment prediction during reversal learning in healthy females but not males.

Authors:  Oliver J Robinson; Holly R Standing; Elise E DeVito; Roshan Cools; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2010-05-22       Impact factor: 4.530

6.  Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion.

Authors:  Zachary Brodnik; Manda Double; George E Jaskiw
Journal:  Psychopharmacology (Berl)       Date:  2013-02-01       Impact factor: 4.530

7.  Acute oral administration of a tyrosine and phenylalanine-free amino acid mixture reduces exercise capacity in the heat.

Authors:  Les Tumilty; Glen Davison; Manfred Beckmann; Rhys Thatcher
Journal:  Eur J Appl Physiol       Date:  2013-01-04       Impact factor: 3.078

8.  Dopamine precursors depletion impairs impulse control in healthy volunteers.

Authors:  Céline Ramdani; Laurence Carbonnell; Franck Vidal; Cyrille Béranger; Alain Dagher; Thierry Hasbroucq
Journal:  Psychopharmacology (Berl)       Date:  2014-07-20       Impact factor: 4.530

9.  Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brain.

Authors:  Marisa Le Masurier; Philip J Cowen; Trevor Sharp
Journal:  Psychopharmacology (Berl)       Date:  2003-09-30       Impact factor: 4.530

10.  Dopamine Depletion Reduces Food-Related Reward Activity Independent of BMI.

Authors:  Sabine Frank; Ralf Veit; Helene Sauer; Paul Enck; Hans-Christoph Friederich; Theresa Unholzer; Ute-Maria Bauer; Katarzyna Linder; Martin Heni; Andreas Fritsche; Hubert Preissl
Journal:  Neuropsychopharmacology       Date:  2015-10-09       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.